1. Home
  2. PINC vs EVO Comparison

PINC vs EVO Comparison

Compare PINC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PINC
  • EVO
  • Stock Information
  • Founded
  • PINC 2013
  • EVO 1993
  • Country
  • PINC United States
  • EVO Germany
  • Employees
  • PINC N/A
  • EVO N/A
  • Industry
  • PINC Other Consumer Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PINC Consumer Discretionary
  • EVO Health Care
  • Exchange
  • PINC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • PINC 1.8B
  • EVO 1.4B
  • IPO Year
  • PINC 2013
  • EVO 2021
  • Fundamental
  • Price
  • PINC $28.15
  • EVO $4.27
  • Analyst Decision
  • PINC Hold
  • EVO Strong Buy
  • Analyst Count
  • PINC 6
  • EVO 1
  • Target Price
  • PINC $26.08
  • EVO $7.00
  • AVG Volume (30 Days)
  • PINC 1.5M
  • EVO 46.5K
  • Earning Date
  • PINC 11-04-2025
  • EVO 11-10-2025
  • Dividend Yield
  • PINC 2.99%
  • EVO N/A
  • EPS Growth
  • PINC N/A
  • EVO N/A
  • EPS
  • PINC 0.22
  • EVO N/A
  • Revenue
  • PINC $1,012,647,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • PINC N/A
  • EVO N/A
  • Revenue Next Year
  • PINC $3.13
  • EVO $10.78
  • P/E Ratio
  • PINC $41.35
  • EVO N/A
  • Revenue Growth
  • PINC N/A
  • EVO N/A
  • 52 Week Low
  • PINC $17.23
  • EVO $2.84
  • 52 Week High
  • PINC $28.79
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • PINC 64.02
  • EVO 67.13
  • Support Level
  • PINC $27.73
  • EVO $3.88
  • Resistance Level
  • PINC $28.05
  • EVO $4.04
  • Average True Range (ATR)
  • PINC 0.17
  • EVO 0.07
  • MACD
  • PINC -0.07
  • EVO 0.02
  • Stochastic Oscillator
  • PINC 76.58
  • EVO 100.00

About PINC Premier Inc.

Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: